IL-22BP Modulates Injury in Acute Pancreatitis but Delays Tissue Recovery in Chronic PancreatitisSummary

Background & Aims: In acute pancreatitis, interleukin (IL)-22 signaling is increased, whereas overall expression of the cytokine paradoxically drops, suggesting an additional level of control. Here, we investigate the regulation of IL-22 signaling by its soluble neutralizing receptor interle...

Full description

Saved in:
Bibliographic Details
Main Authors: Lei Sun, Andrew G. Spiteri, Brian D. Griffith, Yaqing Zhang, Marina Pasca Di Magliano, Alberto C. Olivei, Jake J. McGue, Jacob Edwards, Timothy L. Frankel
Format: Article
Language:English
Published: Elsevier 2025-01-01
Series:Cellular and Molecular Gastroenterology and Hepatology
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2352345X2500061X
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850224114938150912
author Lei Sun
Andrew G. Spiteri
Brian D. Griffith
Yaqing Zhang
Marina Pasca Di Magliano
Alberto C. Olivei
Jake J. McGue
Jacob Edwards
Timothy L. Frankel
author_facet Lei Sun
Andrew G. Spiteri
Brian D. Griffith
Yaqing Zhang
Marina Pasca Di Magliano
Alberto C. Olivei
Jake J. McGue
Jacob Edwards
Timothy L. Frankel
author_sort Lei Sun
collection DOAJ
description Background & Aims: In acute pancreatitis, interleukin (IL)-22 signaling is increased, whereas overall expression of the cytokine paradoxically drops, suggesting an additional level of control. Here, we investigate the regulation of IL-22 signaling by its soluble neutralizing receptor interleukin-22 binding protein (IL-22BP) in the context of both acute and chronic pancreatitis. Methods: Cerulein was used to induce acute and chronic pancreatitis in both wild-type mice and IL-22BP knockout mice. Histology, multiplex immunofluorescence and flow cytometry were performed to compare differences in tissue injury, recovery, fibrosis, and inflammation at various times of recovery. Results: Loss of IL-22BP resulted in increased canonical IL-22 signaling and the expression of the anti-autophagy protein Bcl-XL. This was associated with decreased severity of acute pancreatitis, as evidenced by lower serum amylase and tissue injury. In chronic pancreatitis, IL-22BP expression was induced in the inflammatory and recovery phases and genetic deletion resulted in unchecked IL-22 signaling, as demonstrated by persistent p-Stat3 signaling and proliferation of both epithelial cells and fibroblasts. Loss of IL-22BP increased myeloid cell infiltration, which persisted throughout recovery. Mechanistically, IL-22 activity forced persistent acinar to ductal metaplasia and delayed tissue recovery. Conclusions: IL-22BP plays an important role in modulating IL-22 activity during tissue injury and recovery after pancreatitis. Loss of IL-22BP attenuated acute pancreatitis but promoted chronic fibrosis and inflammation through uncontrolled IL-22 signaling and subsequent deleterious effects on epithelial cells, fibroblasts, and immune infiltration.
format Article
id doaj-art-9ef6995684944896bb1a01a8f785dd5c
institution OA Journals
issn 2352-345X
language English
publishDate 2025-01-01
publisher Elsevier
record_format Article
series Cellular and Molecular Gastroenterology and Hepatology
spelling doaj-art-9ef6995684944896bb1a01a8f785dd5c2025-08-20T02:05:43ZengElsevierCellular and Molecular Gastroenterology and Hepatology2352-345X2025-01-0119810152010.1016/j.jcmgh.2025.101520IL-22BP Modulates Injury in Acute Pancreatitis but Delays Tissue Recovery in Chronic PancreatitisSummaryLei Sun0Andrew G. Spiteri1Brian D. Griffith2Yaqing Zhang3Marina Pasca Di Magliano4Alberto C. Olivei5Jake J. McGue6Jacob Edwards7Timothy L. Frankel8Department of Surgery, University of Michigan, Ann Arbor, Michigan; Rogel Cancer Center, University of Michigan, Ann Arbor, MichiganDepartment of Surgery, University of Michigan, Ann Arbor, Michigan; Rogel Cancer Center, University of Michigan, Ann Arbor, MichiganDepartment of Surgery, University of Michigan, Ann Arbor, Michigan; Rogel Cancer Center, University of Michigan, Ann Arbor, MichiganDepartment of Surgery, University of Michigan, Ann Arbor, Michigan; Rogel Cancer Center, University of Michigan, Ann Arbor, MichiganDepartment of Surgery, University of Michigan, Ann Arbor, Michigan; Rogel Cancer Center, University of Michigan, Ann Arbor, MichiganDepartment of Surgery, University of Michigan, Ann Arbor, Michigan; Rogel Cancer Center, University of Michigan, Ann Arbor, MichiganDepartment of Surgery, University of Michigan, Ann Arbor, Michigan; Rogel Cancer Center, University of Michigan, Ann Arbor, MichiganDepartment of Surgery, University of Michigan, Ann Arbor, Michigan; Rogel Cancer Center, University of Michigan, Ann Arbor, MichiganDepartment of Surgery, University of Michigan, Ann Arbor, Michigan; Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan; Correspondence Address correspondence to: Timothy L. Frankel, MD, 1500 East Medical Center Drive, Ann Arbor, Michigan. 48109.Background & Aims: In acute pancreatitis, interleukin (IL)-22 signaling is increased, whereas overall expression of the cytokine paradoxically drops, suggesting an additional level of control. Here, we investigate the regulation of IL-22 signaling by its soluble neutralizing receptor interleukin-22 binding protein (IL-22BP) in the context of both acute and chronic pancreatitis. Methods: Cerulein was used to induce acute and chronic pancreatitis in both wild-type mice and IL-22BP knockout mice. Histology, multiplex immunofluorescence and flow cytometry were performed to compare differences in tissue injury, recovery, fibrosis, and inflammation at various times of recovery. Results: Loss of IL-22BP resulted in increased canonical IL-22 signaling and the expression of the anti-autophagy protein Bcl-XL. This was associated with decreased severity of acute pancreatitis, as evidenced by lower serum amylase and tissue injury. In chronic pancreatitis, IL-22BP expression was induced in the inflammatory and recovery phases and genetic deletion resulted in unchecked IL-22 signaling, as demonstrated by persistent p-Stat3 signaling and proliferation of both epithelial cells and fibroblasts. Loss of IL-22BP increased myeloid cell infiltration, which persisted throughout recovery. Mechanistically, IL-22 activity forced persistent acinar to ductal metaplasia and delayed tissue recovery. Conclusions: IL-22BP plays an important role in modulating IL-22 activity during tissue injury and recovery after pancreatitis. Loss of IL-22BP attenuated acute pancreatitis but promoted chronic fibrosis and inflammation through uncontrolled IL-22 signaling and subsequent deleterious effects on epithelial cells, fibroblasts, and immune infiltration.http://www.sciencedirect.com/science/article/pii/S2352345X2500061XAcute PancreatitisChronic PancreatitisFibrosisIL-22IL-22BPInflammation
spellingShingle Lei Sun
Andrew G. Spiteri
Brian D. Griffith
Yaqing Zhang
Marina Pasca Di Magliano
Alberto C. Olivei
Jake J. McGue
Jacob Edwards
Timothy L. Frankel
IL-22BP Modulates Injury in Acute Pancreatitis but Delays Tissue Recovery in Chronic PancreatitisSummary
Cellular and Molecular Gastroenterology and Hepatology
Acute Pancreatitis
Chronic Pancreatitis
Fibrosis
IL-22
IL-22BP
Inflammation
title IL-22BP Modulates Injury in Acute Pancreatitis but Delays Tissue Recovery in Chronic PancreatitisSummary
title_full IL-22BP Modulates Injury in Acute Pancreatitis but Delays Tissue Recovery in Chronic PancreatitisSummary
title_fullStr IL-22BP Modulates Injury in Acute Pancreatitis but Delays Tissue Recovery in Chronic PancreatitisSummary
title_full_unstemmed IL-22BP Modulates Injury in Acute Pancreatitis but Delays Tissue Recovery in Chronic PancreatitisSummary
title_short IL-22BP Modulates Injury in Acute Pancreatitis but Delays Tissue Recovery in Chronic PancreatitisSummary
title_sort il 22bp modulates injury in acute pancreatitis but delays tissue recovery in chronic pancreatitissummary
topic Acute Pancreatitis
Chronic Pancreatitis
Fibrosis
IL-22
IL-22BP
Inflammation
url http://www.sciencedirect.com/science/article/pii/S2352345X2500061X
work_keys_str_mv AT leisun il22bpmodulatesinjuryinacutepancreatitisbutdelaystissuerecoveryinchronicpancreatitissummary
AT andrewgspiteri il22bpmodulatesinjuryinacutepancreatitisbutdelaystissuerecoveryinchronicpancreatitissummary
AT briandgriffith il22bpmodulatesinjuryinacutepancreatitisbutdelaystissuerecoveryinchronicpancreatitissummary
AT yaqingzhang il22bpmodulatesinjuryinacutepancreatitisbutdelaystissuerecoveryinchronicpancreatitissummary
AT marinapascadimagliano il22bpmodulatesinjuryinacutepancreatitisbutdelaystissuerecoveryinchronicpancreatitissummary
AT albertocolivei il22bpmodulatesinjuryinacutepancreatitisbutdelaystissuerecoveryinchronicpancreatitissummary
AT jakejmcgue il22bpmodulatesinjuryinacutepancreatitisbutdelaystissuerecoveryinchronicpancreatitissummary
AT jacobedwards il22bpmodulatesinjuryinacutepancreatitisbutdelaystissuerecoveryinchronicpancreatitissummary
AT timothylfrankel il22bpmodulatesinjuryinacutepancreatitisbutdelaystissuerecoveryinchronicpancreatitissummary